TABLE 3.
Cohort | Organism identified by conventional methods | Primary source of bacteremia | Empiric therapy after BioFire BCID result and before final cultures and susceptibilities | Outcome |
---|---|---|---|---|
1 | Aerococcus urinae | Unknown | VAN | Survived |
2 | Aeromonas spp. | Unknown | TZP | Survived |
3 | Anaerococcus prevotii | Unknown | TZP+LZD | Died |
4 | Anaerococcus tetradius | Unknown | CIP+CRO | Survived |
5 | Bacillus coagulans | Unknown | ATM | Survived |
6 | Bacteroides fragilis | Intra-abdominal infection | TZP+VAN+MTZ | Died |
7 | Bacteroides fragilis | Intra-abdominal abscess status, after colonic perforation | MTZ+MIC+TZP+VAN | Survived |
8 | Bacteroides fragilis | Stage IV sacral decubitus ulcer | TZP+VAN | Survived |
9 | Bacteroides fragilis | Unknown | CRO | Survived |
10 | Bacteroides fragilis | Unknown | MTZ+TZP | Survived |
11 | Bacteroides fragilis | Intra-abdominal infection | TZP | Died |
12 | Bacteroides vulgatus | Postpartum endometritis | CRO+GM+MTZ | Survived |
13 | Bacteroides thetaiotaomicron | Unknown | TZP+VAN | Died |
14 | Bacteroides thetaiotaomicron | Intra-abdominal infection with fecal contamination | MTZ+TZP+VAN | Died |
15 | Clostridium citroniae | Pelvic mass vs necrotic tumor vs septic pelvic vein thrombophlebitis | MEM+MTZ+VAN | Survived |
16 | Clostridium clostridioforme | Intra-abdominal infection | VAN+MTZ+FEP | Died |
17 | Corynebacterium amycolatum/freneyi | Aspiration pneumonia | ATM+MTZ+AZM | Survived |
18 | Desulfovibrio desulfuricans | Acute appendicitis | MTZ+MEM | Survived |
19 | Fusobacterium spp. | Shoulder wound infection with prosthesis | CRO+VAN | Survived |
20 | Gram-negative bacillus, unidentified nonfermenter | Unknown | TZP | Died |
21 | Haemophilus parainfluenzae I | Bronchitis | TZP | Survived |
22 | Morganella morganii | UTI | CRO | Survived |
23 | Neisseria mucosa | Unknown | TZP | Survived |
24 | Neisseria spp. (saprophytic) | Spontaneous bacterial peritonitis | CRO | Survived |
25 | Parabacteroides distasonis | Perforated diverticulitis | ATM+MTZ | Survived |
26 | Pediococcus pentosaceus | Abdominal abscess | TZP+VAN | Survived |
27 | Peptoniphilus asaccharolyticus, Micromonas micros | Tubo-ovarian abscess | SAM+CLI | Survived |
28 | Providencia stuartii | UTI | CRO | Survived |
29 | Pseudomonas spp. | Unknown | MTZ+MEM+CIP | Died |
30 | Staphylococcus capitis | Unknown | TZP+VAN | Died |
31 | Staphylococcus capitis | Hemodialysis catheter | VAN | Survived |
32 | Streptococcus, viridans group | UTI | VAN+CRO | Survived |
33 | Streptococcus, viridans group | Endocarditis | AZM+VAN+TZP | Survived |
34 | Streptococcus, viridans group; Lactobacillus spp.; gamma Streptococcus, not group D | Gastric tube site infection with abdominal abscess | TZP+VAN | Survived |
Excluding contaminants and patients discharged or expired prior to BioFire BCID result. TZP, piperacillin-tazobactam; ATM, aztreonam; VAN, vancomycin; CRO, ceftriaxone; MTZ, metronidazole; MEM, meropenem; CIP, ciprofloxacin; SAM, ampicillin-sulbactam; CLI, clindamycin; LZD, linezolid; GM, gentamicin; MIC, micafungin; AZM, azithromycin; FEP, cefepime; DOX, doxycycline.